Revenio Group Corporation (REG1V) - Total Liabilities
Based on the latest financial reports, Revenio Group Corporation (REG1V) has total liabilities worth €30.90 Million EUR (≈ $36.13 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. For the complete balance sheet picture, see balance sheet size of Revenio Group Corporation.
Revenio Group Corporation - Total Liabilities Trend (2000–2025)
This chart illustrates how Revenio Group Corporation's total liabilities have evolved over time, based on quarterly financial data. Explore REG1V strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Revenio Group Corporation Competitors by Total Liabilities
The table below lists competitors of Revenio Group Corporation ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Gladstone Land Corporation
NASDAQ:LAND
|
USA | $515.39 Million |
|
Seanergy Maritime Holdings Corp
NASDAQ:SHIP
|
USA | $330.35 Million |
|
KNOT Offshore Partners LP
NYSE:KNOP
|
USA | $1.04 Billion |
|
Hangzhou Coco Healthcare Products Co.Ltd.
SHE:301009
|
China | CN¥739.23 Million |
|
Shandong Cynda Chemcial Co Ltd
SHG:603086
|
China | CN¥2.08 Billion |
|
Guangdong Failong Crystal Technology Co Ltd
SHE:300460
|
China | CN¥980.04 Million |
|
SMS Electric Co Ltd Zhengzhou
SHE:002857
|
China | CN¥423.10 Million |
|
CPH Chemie und Papier Holding
SW:CPHN
|
Switzerland | CHF182.58 Million |
Liability Composition Analysis (2000–2025)
This chart breaks down Revenio Group Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. Check REG1V financial resilience to evaluate the company's liquid asset resilience ratio.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.26 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.26 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.21 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Revenio Group Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Revenio Group Corporation (2000–2025)
The table below shows the annual total liabilities of Revenio Group Corporation from 2000 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €35.90 Million ≈ $41.97 Million |
+6.75% |
| 2024-12-31 | €33.63 Million ≈ $39.32 Million |
-10.37% |
| 2023-12-31 | €37.52 Million ≈ $43.86 Million |
-16.95% |
| 2022-12-31 | €45.17 Million ≈ $52.81 Million |
-2.12% |
| 2021-12-31 | €46.15 Million ≈ $53.96 Million |
+3.23% |
| 2020-12-31 | €44.71 Million ≈ $52.27 Million |
-1.58% |
| 2019-12-31 | €45.43 Million ≈ $53.11 Million |
+1029.49% |
| 2018-12-31 | €4.02 Million ≈ $4.70 Million |
+31.65% |
| 2017-12-31 | €3.06 Million ≈ $3.57 Million |
-23.76% |
| 2016-12-31 | €4.01 Million ≈ $4.68 Million |
+18.13% |
| 2015-12-31 | €3.39 Million ≈ $3.97 Million |
-53.37% |
| 2014-12-31 | €7.28 Million ≈ $8.51 Million |
-5.26% |
| 2013-12-31 | €7.68 Million ≈ $8.98 Million |
-25.65% |
| 2012-12-31 | €10.33 Million ≈ $12.07 Million |
+23.97% |
| 2011-12-31 | €8.33 Million ≈ $9.74 Million |
-16.56% |
| 2010-12-31 | €9.98 Million ≈ $11.67 Million |
-7.80% |
| 2009-12-31 | €10.83 Million ≈ $12.66 Million |
-4.59% |
| 2008-12-31 | €11.35 Million ≈ $13.27 Million |
-38.31% |
| 2007-12-31 | €18.40 Million ≈ $21.51 Million |
+193.80% |
| 2006-12-31 | €6.26 Million ≈ $7.32 Million |
+9.02% |
| 2005-12-31 | €5.74 Million ≈ $6.72 Million |
+65.00% |
| 2004-12-31 | €3.48 Million ≈ $4.07 Million |
-35.76% |
| 2003-12-31 | €5.42 Million ≈ $6.34 Million |
-28.76% |
| 2002-12-31 | €7.61 Million ≈ $8.89 Million |
-54.55% |
| 2001-12-31 | €16.73 Million ≈ $19.56 Million |
-23.63% |
| 2001-09-30 | €21.91 Million ≈ $25.62 Million |
-5.56% |
| 2000-12-31 | €23.20 Million ≈ $27.13 Million |
-- |
About Revenio Group Corporation
Revenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, the United States, and internationally. The company offers iCare IC100, ST500, and IC200 tonometers; iCare HOME2, a tonometer to measure eye pressure; iCare Sensors that are accessories of iCare tonometer for measuring intraocular pr… Read more